Expanding access to our medicines

Every day, 1,000 young women and girls get HIV, 4,000 lives are lost to TB, and millions who could be helped suffer from serious mental illnesses. Johnson & Johnson’s efforts in tackling these health threats, alongside many others, is why the company has continued to rank among the top three working to expand global access to medicines in low- and middle-income countries according to the Access to Medicine Index (ATMI).